Post Acquisition Codex DNA's acquisition of Eton Bioscience signals potential cross-sell opportunities to combine Eton's sequencing, oligo synthesis, gene delivery, and protein/antibody offerings with Codex's platform capabilities.

Target Market The customer base spans academic institutions, biotech startups, and pharmaceutical companies, suggesting sales motions focused on high-volume orders, research-scale services, and project-specific collaborations.

Portfolio Synergy Eton's diverse services enable end-to-end workflows and cross-selling with Codex DNA, creating opportunities to package sequencing, synthesis, and delivery into integrated solutions.

Strategic Locale Based in San Diego, a leading biotech hub, offering proximity to top universities and research centers to accelerate engagements, pilots, and contract opportunities.

Scale Readiness Mid-sized team and scalable operations align with expanding orders, multi-site collaborations, and service contracts across academic and pharma accounts.